Cover Image
市場調查報告書

多發性神經病變:全球臨床實驗檢討

Polyneuropathies Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 172388
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
多發性神經病變:全球臨床實驗檢討 Polyneuropathies Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月28日 內容資訊: 英文 87 Pages
簡介

本報告提供多發性神經病變相關臨床研究之最新趨勢相關分析,為您彙整疾病·治療方法概要,及G7各國與E7(新興7國)的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,再加上各企業及研究機關的研究進行狀況,及有潛力的藥劑比較等資訊。

簡介

  • 多發性神經病變
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 多發性神經病變臨床實驗數的中樞神經系統臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 多發性神經病變臨床實驗數的中樞神經系統臨床實驗數量所佔的比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 多發性神經病變治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
    • NeurogesX, Inc.
    • CSL Limited
    • Novartis AG
    • LFB S.A.
    • Grifols, S.A.
    • Biogen Idec Inc.
    • Eisai
    • E. Merck KG
    • Astellas Pharma Inc.
  • 有代表性的研究機關醫院臨床實驗概要
    • Odense University Hospital
    • National Center for Research Resources
    • Assistance Publique - Hopitaux de Paris
    • Aarhus University
    • Erasmus MC
    • Skane University Hospital
    • The University of New South Wales
    • Medical University of Vienna
    • Oregon Health & Science University
    • Rigshospitalet

5大臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2263CTIDB

GlobalData's clinical trial report, "Polyneuropathies Global Clinical Trials Review, H2, 2014" provides data on the Polyneuropathies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polyneuropathies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polyneuropathies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Polyneuropathies
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Polyneuropathies
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Polyneuropathies Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • NeurogesX, Inc.
      • Clinical Trial Overview of NeurogesX, Inc.
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • LFB S.A.
      • Clinical Trial Overview of LFB S.A.
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • Biogen Idec Inc.
      • Clinical Trial Overview of Biogen Idec Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Odense University Hospital
      • Clinical Trial Overview of Odense University Hospital
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Skane University Hospital
      • Clinical Trial Overview of Skane University Hospital
      • The University of New South Wales
      • Clinical Trial Overview of The University of New South Wales
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Polyneuropathies Therapeutics, Global, Clinical Trials by Region, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Polyneuropathies to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Polyneuropathies to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Polyneuropathies Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Polyneuropathies Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Polyneuropathies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by LFB S.A., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2014*
  • Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*

List of Figures

  • Polyneuropathies Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Polyneuropathies Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Polyneuropathies to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Polyneuropathies to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Polyneuropathies Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Polyneuropathies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Polyneuropathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top